CCP
FUSN

Clough Capital Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Clough Capital Partners’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-399,399
Closed -$4.69M – 176
2020
Q4 		$4.69M Sell
399,399
-3,401
-0.8% -$42.7K 0.33% 72
2020
Q3 		$4.84M Hold
402,800
– – 0.35% 68
2020
Q2 		$7.04M Buy
+402,800
New +$7.02M 0.69% 61

Other funds holding FUSN

JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Clough Capital Partners's FUSN Position: Q1 2021 in Review

Clough Capital Partners sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2021, closing a stake of 399,399 shares — an estimated $4.69M sold.

Clough Capital Partners first reported a position in FUSN in Q2 2020 and held it in 3 quarters. The position peaked at $7.04M in Q2 2020. 38 funds tracked by Wall St. Rank hold FUSN as of Q1 2021.

  • Clough Capital Partners reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2021 after selling out during the quarter.
  • Clough Capital Partners sold 399,399 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2021, an estimated $4.69M.
  • Clough Capital Partners first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 3 quarters.
  • Clough Capital Partners's Fusion Pharmaceuticals Inc. Common Shares position peaked at $7.04M in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2021.

Based on Clough Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.